FDA Inspection 607598 — Central Pennsylvania Blood Bank
The FDA completed an inspection of Central Pennsylvania Blood Bank on August 26, 2009 in Ephrata, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 26, 2009
- Fiscal Year
- 2009
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Ephrata, PA (United States)